Skip to main content
Caplight Logo









IMVARIA Inc.

IMVARIA Inc.

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://imvaria.com/

Last Round

Strategic

Jan 7, 2026

Company Overview

IMVARIA Inc. is a healthcare technology company that develops artificial intelligence-driven digital biomarker solutions for the non-invasive diagnosis and assessment of interstitial lung diseases and idiopathic pulmonary fibrosis.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

medical AIsoftware as a medical deviceSaMDdigital biomarkerpulmonary diagnosticsmedical imaging AIinterstitial lung diseaseILDclinical decision supportAI diagnosticsradiology AInon-invasive diagnosisidiopathic pulmonary fibrosisIPFhealth techAI-in-a-box

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

IMVARIA Inc. Comparables

Compare IMVARIA Inc. with similar companies based on industry and business-model similarity.

IMVARIA Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Revenio Group
83%
Brainomix
78%
Optellum
78%

IMVARIA Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJan 7, 2026
GrantSep 3, 2025
AcceleratorJun 15, 2021
AcceleratorJun 10, 2021

Key People

Founding team and executive leadership

Michael C. Muelly

Founder & CTO

Founding Team

Joshua Reicher

Co-Founder And CEO

Founding Team

IMVARIA Inc. Investors

Notable investors and investment history

IMVARIA Inc. investors
InvestorRounds
UCSF Rosenman InstituteAccelerator
MedTech InnovatorAccelerator
NIH RADxGrant
Inhealth VenturesStrategic
Cedar Crest CapitalStrategic

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 3, 2025

    Received grant funding from NIH RADx.

  • May 18, 2025

    Presented AI diagnostic referral service results at ATS 2025.

IMVARIA Inc. Filings

Explore SEC and related filing metadata, where available.

IMVARIA Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about IMVARIA Inc.'s valuation, stock price, and market status.

Is IMVARIA Inc. a public or private company?

IMVARIA Inc. is a private company.

What is the current stock price of IMVARIA Inc.?

IMVARIA Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is IMVARIA Inc. worth (valuation)?

Valuation information for IMVARIA Inc. is not publicly available.

Can I buy IMVARIA Inc. stock?

IMVARIA Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was IMVARIA Inc.'s last funding round?

IMVARIA Inc.'s most recent funding round was Early Funding on January 7, 2026.

Who are the main investors in IMVARIA Inc.?

Key investors in IMVARIA Inc. include NIH RADx, Inhealth Ventures.

Will IMVARIA Inc. IPO soon?

No public IPO plans have been announced for IMVARIA Inc..

How can I track IMVARIA Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor IMVARIA Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerkeley, California
Employee Range8
Year Founded2019
Last FundingJan 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?